FDA Threatens To Pull Blood Pressure Drug
By Hilary Russ ( August 16, 2010, 6:09 PM EDT) -- The U.S. Food and Drug Administration said Monday it was considering withdrawing its approval of the drug midodrine hydrochloride because Shire PLC and generic-drug manufacturers did not perform clinical benefits studies as required after the medicine reached the market....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.